Episode Details
Back to EpisodesGrail's Stock Surges on Early Cancer Detection Promise
Published 22 hours ago
Description
Grails stock surges as investors eye potential payoff of multi-cancer early detection test, despite high risks. The Galleri test missed late-stage cancer reduction goal but detected more early-stage cancers. A new Medicare law and managements push for FDA approval fuel optimism. Analysts upgrade stock and set price target, attracting bold investors.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/4d57ed03f3afe512